87 related articles for article (PubMed ID: 16278681)
1. CRIPak, a novel endogenous Pak1 inhibitor.
Talukder AH; Meng Q; Kumar R
Oncogene; 2006 Mar; 25(9):1311-9. PubMed ID: 16278681
[TBL] [Abstract][Full Text] [Related]
2. Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity.
Rayala SK; Kumar R
Biomed Pharmacother; 2007 Aug; 61(7):408-11. PubMed ID: 17604944
[TBL] [Abstract][Full Text] [Related]
3. P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation.
Rayala SK; Talukder AH; Balasenthil S; Tharakan R; Barnes CJ; Wang RA; Aldaz CM; Khan S; Kumar R
Cancer Res; 2006 Feb; 66(3):1694-701. PubMed ID: 16452229
[TBL] [Abstract][Full Text] [Related]
4. Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1.
Vadlamudi RK; Li F; Adam L; Nguyen D; Ohta Y; Stossel TP; Kumar R
Nat Cell Biol; 2002 Sep; 4(9):681-90. PubMed ID: 12198493
[TBL] [Abstract][Full Text] [Related]
5. Regulation of phosphoglucomutase 1 phosphorylation and activity by a signaling kinase.
Gururaj A; Barnes CJ; Vadlamudi RK; Kumar R
Oncogene; 2004 Oct; 23(49):8118-27. PubMed ID: 15378030
[TBL] [Abstract][Full Text] [Related]
6. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
Holm C; Rayala S; Jirström K; Stål O; Kumar R; Landberg G
J Natl Cancer Inst; 2006 May; 98(10):671-80. PubMed ID: 16705121
[TBL] [Abstract][Full Text] [Related]
7. Nuclear p21-activated kinase 1 in breast cancer packs off tamoxifen sensitivity.
Rayala SK; Molli PR; Kumar R
Cancer Res; 2006 Jun; 66(12):5985-8. PubMed ID: 16778166
[TBL] [Abstract][Full Text] [Related]
8. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
9. Regulation of L-type calcium channel and delayed rectifier potassium channel activity by p21-activated kinase-1 in guinea pig sinoatrial node pacemaker cells.
Ke Y; Lei M; Collins TP; Rakovic S; Mattick PA; Yamasaki M; Brodie MS; Terrar DA; Solaro RJ
Circ Res; 2007 May; 100(9):1317-27. PubMed ID: 17413045
[TBL] [Abstract][Full Text] [Related]
10. P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium.
Wang RA; Mazumdar A; Vadlamudi RK; Kumar R
EMBO J; 2002 Oct; 21(20):5437-47. PubMed ID: 12374744
[TBL] [Abstract][Full Text] [Related]
11. A PAK1 Mutational Hotspot Within the Regulatory CRIPaK Domain is Associated With Severe Neurodevelopmental Disorders in Children.
Scorrano G; D'Onofrio G; Accogli A; Severino M; Buchert R; Kotzaeridou U; Iapadre G; Farello G; Iacomino M; Dono F; Di Francesco L; Fiorile MF; La Bella S; Corsello A; Calì E; Di Rosa G; Gitto E; Verrotti A; Fortuna S; Soler MA; Chiarelli F; Oehl-Jaschkowitz B; Haack TB; Zara F; Striano P; Salpietro V
Pediatr Neurol; 2023 Dec; 149():84-92. PubMed ID: 37820543
[TBL] [Abstract][Full Text] [Related]
12. The BASH/BLNK/SLP-65-associated protein BNAS1 regulates antigen-receptor signal transmission in B cells.
Katahira T; Imamura Y; Kitamura D
Int Immunol; 2006 Apr; 18(4):545-53. PubMed ID: 16481341
[TBL] [Abstract][Full Text] [Related]
13. Identification of dynein light chain 2 as an interaction partner of p21-activated kinase 1.
Lu J; Sun Q; Chen X; Wang H; Hu Y; Gu J
Biochem Biophys Res Commun; 2005 May; 331(1):153-8. PubMed ID: 15845372
[TBL] [Abstract][Full Text] [Related]
14. Spatiotemporal regulation of the Pak1 kinase.
Parrini MC; Matsuda M; de Gunzburg J
Biochem Soc Trans; 2005 Aug; 33(Pt 4):646-8. PubMed ID: 16042564
[TBL] [Abstract][Full Text] [Related]
15. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
16. ERAP75 functions as a coactivator to enhance estrogen receptor alpha transactivation in prostate stromal cells.
Chen M; Ni J; Zhang Y; Muyan M; Yeh S
Prostate; 2008 Sep; 68(12):1273-82. PubMed ID: 18563714
[TBL] [Abstract][Full Text] [Related]
17. P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer.
Ito M; Nishiyama H; Kawanishi H; Matsui S; Guilford P; Reeve A; Ogawa O
J Urol; 2007 Sep; 178(3 Pt 1):1073-9. PubMed ID: 17644138
[TBL] [Abstract][Full Text] [Related]
18. Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer.
Bostner J; Ahnström Waltersson M; Fornander T; Skoog L; Nordenskjöld B; Stål O
Oncogene; 2007 Oct; 26(49):6997-7005. PubMed ID: 17486065
[TBL] [Abstract][Full Text] [Related]
19. Novel estrogen receptor beta transcript variants identified in human breast cancer cells affect cell growth and apoptosis of COS-1 cells.
Treeck O; Pfeiler G; Horn F; Federhofer B; Houlihan H; Vollmer A; Ortmann O
Mol Cell Endocrinol; 2007 Jan; 264(1-2):50-60. PubMed ID: 17095148
[TBL] [Abstract][Full Text] [Related]
20. Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes.
Vadlamudi RK; Bagheri-Yarmand R; Yang Z; Balasenthil S; Nguyen D; Sahin AA; den Hollander P; Kumar R
Cancer Cell; 2004 Jun; 5(6):575-85. PubMed ID: 15193260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
